SCHEMBL17431201

SCHEMBL17431201

c1ccc2c(c1)oc1ccc3c(c12)-c1c(ccc2sc4ccccc4c12)-c1ccc2sc4ccccc4c2c1-c1c-3ccc2oc3ccccc3c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ TDP1 Q9NUW8 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ DUSP3 P51452 1/20 0.42
▸ BLM P54132 1/20 0.42
▸ PTPN5 P54829 1/20 0.42
▸ PTPN11 Q06124 1/20 0.42
▸ MCL1 Q07820 1/20 0.42
▸ CTDSP1 Q9GZU7 1/20 0.42
▸ GPR3 P46089 1/20 0.39
▸ HPGD P15428 4/20 0.35
▸ MAOA P21397 4/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ GLA P06280 1/20 0.35
▸ PGAM1 P18669 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21726241 0.87 PARP1 (0.41) MAPTMEN1KMT2ATDP1POLB
SCHEMBL17930626 0.85 GPR3 (0.46) MAPTMEN1KMT2ATDP1POLB
SCHEMBL17431155 0.85 GPR3 (0.54) MAPTMEN1KMT2ATDP1POLB
SCHEMBL17431206 0.84 ALOX5 (0.40) MAPTMEN1KMT2ATDP1POLB
SCHEMBL16919420 0.83 GPR3 (0.45) MAPTMEN1KMT2ATDP1POLB
SCHEMBL17431189 0.83 KDM4E (0.36) MAPTMEN1KMT2ATDP1POLB
SCHEMBL17431154 0.83 MAOA (0.48) MAPTMEN1KMT2ATDP1HPGD
SCHEMBL17431186 0.82 AHR (0.41) MAPTMEN1KMT2ATDP1POLB
SCHEMBL17431205 0.82 AHR (0.41) MAPTMEN1KMT2ATDP1POLB
SCHEMBL17431197 0.82 GPR3 (0.37) MAPTMEN1KMT2ATDP1GPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10566546-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-02-18 — — US disclosed
US-20160013422-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-01-14 — — US disclosed
US-20160013422-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-01-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160013422-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OXER1, NR4A3, OXSR1 MAPT 4272/4885MEN1 2326/4885KMT2A 3991/4885
US-10566546-B2 Organic electroluminescent materials and devices OXER1, NR4A3, OXSR1 MAPT 4272/4885MEN1 2326/4885KMT2A 3991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback